|
CTNM Contineum Therapeutics Inc 1855175 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-15,154,000.00 |
| Balance Sheet |
|
Current Assets
|
$242,580,000.00 |
|
Assets
|
$250,367,000.00 |
|
Current Liabilities
|
$6,526,000.00 |
|
Liabilities
|
$10,707,000.00 |
|
Equity
|
$239,660,000.00 |
|
Shares Out
|
2384426.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-27,767,000.00 |
|
Investing Cash Flow
|
$-34,454,000.00 |
| Market Analysis |
Market Cap
|
$38,198,504.52 |
|
Price
|
$16.02 |
|
BVPS
|
100.51 |
|
PB
|
0.16 |
|
EPS
|
-0.40 |
|
FCF
|
$-28,085,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:40 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:31 |
|
| Apr |
May |
Jun |
| 2026-03-05 |
-0.49 |
|
|
2026-05-05 |
-0.39 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-05 |
-0.62 |
|
| Oct |
Nov |
Dec |
|
|
2025-10-30 |
-0.45 |
|
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CTNM documents filed with the SEC.
CTNM Filings
Clear
